Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1)
- PMID: 23675445
- PMCID: PMC3652859
- DOI: 10.1371/journal.pone.0062955
Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1)
Abstract
New Delhi metallo-β-lactmase-1 (NDM-1) has recently attracted extensive attention for its biological activities to catalyze the hydrolysis of almost all of β-lactam antibiotics. To study the catalytic property of NDM-1, the steady-kinetic parameters of NDM-1 toward several kinds of β-lactam antibiotics have been detected. It could effectively hydrolyze most β-lactams (k cat/K m ratios between 0.03 to 1.28 µmol⁻¹.s⁻¹), except aztreonam. We also found that thiophene-carboxylic acid derivatives could inhibit NDM-1 and have shown synergistic antibacterial activity in combination with meropenem. Flexible docking and quantum mechanics (QM) study revealed electrostatic interactions between the sulfur atom of thiophene-carboxylic acid derivatives and the zinc ion of NDM-1, along with hydrogen bond between inhibitor and His189 of NDM-1. The interaction models proposed here can be used in rational design of NDM-1 inhibitors.
Conflict of interest statement
Figures
References
-
- Ambler RP (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289: 321–31. - PubMed
-
- Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, et al. (2009) Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53: 5046–5054. - PMC - PubMed
-
- Rolain JM, Parola P, Cornaglia G (2010) New Delhi metallo-β-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect 16: 1699–1701. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
